Wellcome Trust’s PE portfolio turns cashflow negative amid capital call slowdown

The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.

ByCarmela Mendoza

10 January 2023•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Investors Western Europe Buyout Venture capital Endowments Limited Partners Front page

Wellcome Trust’s PE portfolio turns cashflow negative amid capital call slowdown

Advent International

Pacenote Capital

Silver Lake

The Carlyle Group

The Wellcome Trust

Related articles